In a human erythroleukemic cell line K562, mortalin (GRP75) promotes C5b-9 shedding in vesicles (29), while blocking EV release by mortalin knockdown or treatment with antagonist peptides restored complement mediated cytotoxicity in K562 and two breast cancer cells lines (30). This evidence concerns the gene HSPA9 and breast carcinoma.